Peter Fromen

Chief Commercial Officer, Pacific Biosciences.

Companies

Pacific BiosciencesChief Commercial Officer Jan 12, 2021 to Mar 4, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pacific Biosciences PACB190,280 shares²$372.9K at $1.96Mar 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 2, 2022Granted 50,000 shares of Pacific Biosciences²
Jan 11, 2022Sold 19,720 shares at $14.30 of Pacific Biosciences³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPacific Biosciences, Chief Commercial Officer
2
SEC EDGARPacific Biosciences shares after the filing of Mar 2, 2022
3
SEC EDGARForm 4 filed Jan 13, 2022